XTX Topco’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$356K Buy
75,820
+65,220
+615% +$338K 0.01% 2648
2026
Q2
$49.7K Sell
10,600
-12,004
-53% -$88.5K ﹤0.01% 3722
2026
Q1
$149K Sell
22,604
-12,801
-36% -$83.9K ﹤0.01% 2957
2025
Q4
$204K Sell
35,405
-2,418
-6% -$12.9K 0.01% 2387
2025
Q3
$165K Buy
+37,823
New +$165K 0.01% 1909
2025
Q2
– Sell
-12,323
Closed -$70.8K – 3204
2025
Q1
$70.8K Sell
12,323
-4,823
-28% -$29.4K ﹤0.01% 1934
2024
Q4
$136K Buy
17,146
+10,068
+142% +$55.7K 0.01% 1695
2024
Q3
$28.9K Buy
+7,078
New +$28.4K ﹤0.01% 1785
2023
Q3
– Sell
-1,446
Closed -$18.5K – 2034
2023
Q2
$18.5K Buy
+1,446
New +$22.6K ﹤0.01% 1323

Other funds holding UNCY

XTX Topco's UNCY Position: Q3 2026 in Review

XTX Topco increased its Unicycive Therapeutics (UNCY) stake by 615% in Q3 2026, buying an estimated $338K and bringing the position to 75,820 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #2648.

XTX Topco first reported a position in UNCY in Q2 2023 and has held it in 9 quarters since. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • XTX Topco held 75,820 shares of Unicycive Therapeutics worth $356K as of Q3 2026.
  • XTX Topco bought 65,220 Unicycive Therapeutics shares in Q3 2026, an estimated $338K.
  • Unicycive Therapeutics made up 0.01% of XTX Topco's portfolio in Q3 2026, its #2648 holding.
  • XTX Topco first reported a position in Unicycive Therapeutics in Q2 2023 and has held it in 9 quarters since.
  • 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.